EP300 and Alzheimer disease: In this regard, while increased p300/CBP HAT activity was observed in the brains of FTLD-tau patients (80), p300/CBP levels, and activity were found to be lower in the frontal cortex and hippocampus of AD patients (81) and in a mouse model of AD (82).